Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Pennington, R. Fisher (1981)
Dicyclohexylcarbodiimide modification of bovine heart mitochondrial transhydrogenase.The Journal of biological chemistry, 256 17
E. Ariëns (1967)
THE STRUCTURE‐ACTIVITY RELATIONSHIPS OF BETA ADRENERGIC DRUGS AND BETA ADRENERGIC BLOCKING DRUGSAnnals of the New York Academy of Sciences, 139
M. Vaillancourt, B. Vanasse, N. Berre, E. Cohen, G. Sauvé (1994)
Synthesis of novel inhibitors of the HIV-1 protease: difunctional enols of simple N-protected amino acids.Bioorganic & medicinal chemistry, 2 5
I. Ali, I. Al-Masoudi, B. Saeed, N. Al-Masoudi, P. Colla (2005)
Amino acid derivatives, part 2: Synthesis, antiviral, and antitumor activity of simple protected amino acids functionalized at N‐terminus with naphthalene side chainHeteroatom Chemistry, 16
A. Carr, D. Cooper (2000)
Adverse effects of antiretroviral therapyThe Lancet, 356
L. Stuyver, S. Lostia, S. Patterson, Jeremy Clark, Kyoichi Watanabe, M. Otto, K. Pankiewicz (2002)
Inhibitors of the IMPDH Enzyme as Potential Anti-Bovine Viral Diarrhoea Virus AgentsAntiviral Chemistry and Chemotherapy, 13
A. Iversen, R. Shafer, K. Wehrly, M. Winters, J. Mullins, B. Chesebro, T. Merigan (1996)
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyJournal of Virology, 70
H. Sham, D. Kempf, Akhteruzammen Molla, K. Marsh, G. Kumar, C. Chen, W. Kati, K. Stewart, R. Lal, A. Hsu, D. Betebenner, M. Korneyeva, S. Vasavanonda, E. McDONALD, A. Saldivar, N. Wideburg, Xiaoqi Chen, P. Niu, Chang Park, Venkata Jayanti, B. Grabowski, G. Granneman, E. Sun, A. Japour, J. Leonard, J. Plattner, D. Norbeck (1998)
ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus ProteaseAntimicrobial Agents and Chemotherapy, 42
W. König, R. Geiger (1970)
Eine neue Methode zur Synthese von Peptiden: Aktivierung der Carboxylgruppe mit Dicyclohexylcarbodiimid unter Zusatz von 1‐Hydroxy‐benzotriazolenChemische Berichte, 103
A. Mastrolorenzo, A. Scozzafava, C. Supuran (2000)
4-toluenesulfonylureido derivatives of amines, amino acids and dipeptides: a novel class of potential antitumor agents.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 11 4
D. Kempf, Kennan MARSHt, J. Denissen, C. Flentge, Brian Green, L. Fino, Chang Parks, N. Wideburg, A. Saldivar, Lisa Ruizll, W. Kati, H. Sham, T. Robins, Kent Stewartt, J. Plattner, John LEONARDtt, D. Norbeck (1995)
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.Proceedings of the National Academy of Sciences of the United States of America, 92
I. Nizova, V. Krasnov, G. Levit, M. Kodess (2002)
Synthesis of (2S,4S)-4-phenylamino-5-oxoproline derivativesAmino Acids, 22
A. Casini, A. Scozzafava, C. Supuran (2002)
Cysteine-modifying agents: a possible approach for effective anticancer and antiviral drugs.Environmental Health Perspectives, 110
E. Clercq (2001)
New developments in anti-HIV chemotherapyFarmaco, 56
K. Yu, W. Harte, P. Spinazze, John Martin, M. Mansuri (1993)
Synthesis of 1,3-diamino-2-hydroxypropane derivatives as pseudosymmetric HIV protease inhibitorsBioorganic & Medicinal Chemistry Letters, 3
D. Durantel, Sandra Carrouée-Durantel, N. Branza-Nichita, R. Dwek, N. Zitzmann (2004)
Effects of Interferon, Ribavirin, and Iminosugar Derivatives on Cells Persistently Infected with Noncytopathic Bovine Viral Diarrhea VirusAntimicrobial Agents and Chemotherapy, 48
K. Santhosh, E. Clercq, C. Pannecouque, M. Witvrouw, T. Loftus, J. Turpin, R. Buckheit, M. Cushman (2000)
Anti-HIV activity of a series of cosalane amino acid conjugates.Bioorganic & medicinal chemistry letters, 10 22
M. Hirsch, R. D’Aquila (1993)
Therapy for human immunodeficiency virus infection.The New England journal of medicine, 328 23
Hiroaki Mitsuya, K. Weinhold, Furman Pa, Stern Mh, S. Lehrman, R. Gallo, D. Bolognesi, D. Barry, S. Broder (1985)
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences of the United States of America, 82 20
I. Ali, E. Ashry, R. Schmidt (2004)
Imidomethylation of C-nucleophiles using O-phthalimidomethyl trichloroacetimidate and catalytic amounts of TMSOTfTetrahedron, 60
R. LeMahieu, M. Carson, R. Han, W. Nason, M. O'Donnell, D. Brown, H. Crowley, A. Welton (1987)
Substituted (aryloxy)alkanoic acids as antagonists of slow-reacting substance of anaphylaxis.Journal of medicinal chemistry, 30 1
J. Gallant (2002)
Initial therapy of HIV infection.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 25 3
Henri Goldstein, Ernest Cornamusaz (1932)
Sur la β‐naphtoyl‐hydrazine et l'acide 3‐hydrazino‐2‐naphtoïqueHelvetica Chimica Acta, 15
Joly, Yeni (2000)
New trends in antiretroviral therapy for HIV infection.European journal of internal medicine, 11 6
A. Asagarasu, T. Uchiyama, K. Achiwa (1998)
Syntheses of HIV-protease inhibitors having a peptide moiety which binds to GP120.Chemical & pharmaceutical bulletin, 46 4
S. Young, S. Britcher, L. Tran, L. Payne, W. Lumma, T. Lyle, J. Huff, P. Anderson, D. Olsen, S. Carroll, D. Pettibone, J. O'brien, R. Ball, S. Balani, J. Lin, I. Chen, W. Schleif, V. Sardana, W. Long, V. Byrnes, E. Emini (1995)
L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptaseAntimicrobial Agents and Chemotherapy, 39
M. Alley, Dominic Scudiere, A. Monks, M. Hursey, M. Czerwiński, D. Fine, B. Abbott, J. Mayo, R. Shoemaker, M. Boyd (1988)
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.Cancer research, 48 3
D. Brown, M. Horsman, D. Hirst, J. Brown (1984)
Enhancement of melphalan cytotoxicity in vivo and in vitro by inhibitors of poly (ADP-ribose) polymerase.International journal of radiation oncology, biology, physics, 10 9
A. Rossum, P. Fraaij, R. Groot (2002)
Efficacy of highly active antiretroviral therapy in HIV-1 infected children.The Lancet. Infectious diseases, 2 2
A. Cleland, P. Nettleton, L. Jarvis, P. Simmonds (1999)
Use of Bovine Viral Diarrhoea Virus as an Internal Control for Amplification of Hepatitis C VirusVox Sanguinis, 76
A series of peptide derivatives conjugated naphthalene residue 11–25, the glycoside 27 as well as the 7‐glycoside 30, and the 2‐(2‐hydroxy‐3‐(N‐benzyl‐N‐isopropylamino)propoxy)naphthalene bearing methionine 31 were synthesized. The new compounds were evaluated in vitro for cytotoxicity against HIV‐1 and bovine viral diarrhea virus (BVDV), where 31 showed remarkable activity against HIV‐1. The cytotoxicity, in vitro, of 11–25 and 27 was assayed against a panel of tumor cell lines consisting of CD4 human T‐cells containing an integrated T‐leukemia virus type 1 (HTLV‐1), CD4 human acute T‐lympho‐ blastic leukemia, splenic B‐lympho‐blastoid cells, acute B‐lymphoblastic leukemia, mela‐noma, breast adenocarcinoma, lung squamous carcinoma, hepatocellular carcinoma, prostate carcinoma, foreskin fibroblasts, and lung fibroblasts. © 2005 Wiley Periodicals, Inc. Heteroatom Chem 16:576–585, 2005; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/hc.20149
Heteroatom Chemistry – Wiley
Published: Jan 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.